Resources from the same session
Dissecting the molecular differences and clinical outcomes of EGFR patients with Exon 19 deletion and Exon 21 L858R mutations
Presenter: Yi-Long Wu
Session: Pfizer - Beyond 2020: Targeting EGFR Exon 19 and Exon 21 L858R in the New Era
Resources:
Webcast
Case based discussion
Presenter: Ullas Batra
Session: Pfizer - Beyond 2020: Targeting EGFR Exon 19 and Exon 21 L858R in the New Era
Resources:
Webcast
Panel discussion and closing
Presenter: Nellie Cheah Lay Chin
Session: Pfizer - Beyond 2020: Targeting EGFR Exon 19 and Exon 21 L858R in the New Era
Resources:
Webcast